Prof. Hans Lennernäs Uppsala University, Sweden

Professor Hans Lennernäs is a Professor of Biopharmaceutics at Uppsala University, Sweden, and formerly an Adjunct Professor at the University of Copenhagen (2000–2012). His research focuses on developing innovative strategies for targeted drug delivery to improve the treatment of metabolic, endocrine, and cancer diseases. He was a Principal Investigator in... read morethe landmark collaboration between the FDA, the University of Michigan, and the Swedish Medical Products Agency that led to the creation of the Biopharmaceutics Classification System (BCS), now a globally adopted regulatory framework and considered one of the most significant innovations in clinical pharmacology of the past 50 years.

Prof. Lennernäs has built one of the field’s most extensive human pharmacokinetic databases and is widely recognised for his contributions to drug absorption, gastrointestinal physiology, and oral drug delivery. He has authored more than 275 peer-reviewed publications, delivered over 350 invited lectures, and supervised numerous doctoral researchers. His work has been supported by major national and international funding bodies and honoured with multiple prestigious awards, including the AAPS Fellow designation, the Humboldt Research Award, and innovation awards for several therapeutic products.

In addition to holding more than 23 patents, Prof. Lennernäs has co-founded several biotech start-ups and continues to lead translational research in targeted therapies for prostate cancer, liver cancer, endocrine disorders, and gastrointestinal diseases.